Literature DB >> 29165633

Genetic Variation at IFNL4 Influences Extrahepatic Interferon-Stimulated Gene Expression in Chronic HCV Patients.

Brad R Rosenberg1,2, Catherine A Freije1, Naoko Imanaka3, Spencer T Chen1, Jennifer L Eitson2, Rachel Caron1, Skyler A Uhl1, Marija Zeremski4, Andrew Talal4, Ira M Jacobson4, Charles M Rice3, John W Schoggins5.   

Abstract

Polymorphisms at IFNL4 strongly influence spontaneous resolution and interferon therapeutic response in hepatitis C virus (HCV) infection. In chronic HCV, unfavorable alleles are associated with elevated interferon (IFN)-stimulated gene (ISG) expression in the liver, but extrahepatic effects are less well characterized. We used RNA sequencing (RNA-Seq) to examine whether IFNL4 genetic variation (rs368234815) modulates ISG expression in peripheral blood mononuclear cells (PBMC) during chronic HCV infection. ISG expression was elevated in unstimulated PBMC homozygous for the unfavorable ΔG IFNL4 variant; expression following IFN-α stimulation was comparable across genotypes. These findings suggest that lambda interferons may have broader systemic effects during HCV infection.
© The Author(s) 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Hepatitis C; IFNL4; interferon; interferon-stimulated genes; peripheral blood mononuclear cells

Mesh:

Substances:

Year:  2018        PMID: 29165633      PMCID: PMC5853921          DOI: 10.1093/infdis/jix593

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  16 in total

1.  Global transcriptional response to interferon is a determinant of HCV treatment outcome and is modified by race.

Authors:  Xiao-Song He; Xuhuai Ji; Matthew B Hale; Ramsey Cheung; Aijaz Ahmed; Yaqian Guo; Garry P Nolan; Lawrence M Pfeffer; Teresa L Wright; Neil Risch; Robert Tibshirani; Harry B Greenberg
Journal:  Hepatology       Date:  2006-08       Impact factor: 17.425

2.  Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C.

Authors:  Masao Honda; Akito Sakai; Tatsuya Yamashita; Yasunari Nakamoto; Eishiro Mizukoshi; Yoshio Sakai; Taro Yamashita; Mikiko Nakamura; Takayoshi Shirasaki; Katsuhisa Horimoto; Yasuhito Tanaka; Katsushi Tokunaga; Masashi Mizokami; Shuichi Kaneko
Journal:  Gastroenterology       Date:  2010-04-29       Impact factor: 22.682

3.  Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus.

Authors:  Alexander J Thompson; Andrew J Muir; Mark S Sulkowski; Dongliang Ge; Jacques Fellay; Kevin V Shianna; Thomas Urban; Nezam H Afdhal; Ira M Jacobson; Rafael Esteban; Fred Poordad; Eric J Lawitz; Jonathan McCone; Mitchell L Shiffman; Greg W Galler; William M Lee; Robert Reindollar; John W King; Paul Y Kwo; Reem H Ghalib; Bradley Freilich; Lisa M Nyberg; Stefan Zeuzem; Thierry Poynard; David M Vock; Karen S Pieper; Keyur Patel; Hans L Tillmann; Stephanie Noviello; Kenneth Koury; Lisa D Pedicone; Clifford A Brass; Janice K Albrecht; David B Goldstein; John G McHutchison
Journal:  Gastroenterology       Date:  2010-04-24       Impact factor: 22.682

4.  IL-29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection.

Authors:  Heiyoung Park; Elisavet Serti; Onyinyechi Eke; Brian Muchmore; Ludmila Prokunina-Olsson; Stefania Capone; Antonella Folgori; Barbara Rehermann
Journal:  Hepatology       Date:  2012-11-19       Impact factor: 17.425

Review 5.  IFN-λ4: the paradoxical new member of the interferon lambda family.

Authors:  Thomas R O'Brien; Ludmila Prokunina-Olsson; Raymond P Donnelly
Journal:  J Interferon Cytokine Res       Date:  2014-04-30       Impact factor: 2.607

6.  Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes.

Authors:  Ewa Terczyńska-Dyla; Stephanie Bibert; Francois H T Duong; Ilona Krol; Sanne Jørgensen; Emilie Collinet; Zoltán Kutalik; Vincent Aubert; Andreas Cerny; Laurent Kaiser; Raffaele Malinverni; Alessandra Mangia; Darius Moradpour; Beat Müllhaupt; Francesco Negro; Rosanna Santoro; David Semela; Nasser Semmo; Markus H Heim; Pierre-Yves Bochud; Rune Hartmann
Journal:  Nat Commun       Date:  2014-12-23       Impact factor: 14.919

7.  Association of IL28B genotype with fibrosis progression and clinical outcomes in patients with chronic hepatitis C: a longitudinal analysis.

Authors:  Mazen Noureddin; Elizabeth C Wright; Harvey J Alter; Shauna Clark; Emmanuel Thomas; Richard Chen; Xiongce Zhao; Cathy Conry-Cantilena; David E Kleiner; T Jake Liang; Marc G Ghany
Journal:  Hepatology       Date:  2013-09-30       Impact factor: 17.425

8.  Camera: a competitive gene set test accounting for inter-gene correlation.

Authors:  Di Wu; Gordon K Smyth
Journal:  Nucleic Acids Res       Date:  2012-05-25       Impact factor: 16.971

9.  voom: Precision weights unlock linear model analysis tools for RNA-seq read counts.

Authors:  Charity W Law; Yunshun Chen; Wei Shi; Gordon K Smyth
Journal:  Genome Biol       Date:  2014-02-03       Impact factor: 13.583

10.  TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions.

Authors:  Daehwan Kim; Geo Pertea; Cole Trapnell; Harold Pimentel; Ryan Kelley; Steven L Salzberg
Journal:  Genome Biol       Date:  2013-04-25       Impact factor: 13.583

View more
  14 in total

1.  The IFNL4 Gene Is a Noncanonical Interferon Gene with a Unique but Evolutionarily Conserved Regulation.

Authors:  Hao Zhou; Michelle Møhlenberg; Ewa Terczyńska-Dyla; Kasper Grønbjerg Winther; Nanna Hougaard Hansen; Johan Vad-Nielsen; Laura Laloli; Ronald Dijkman; Anders Lade Nielsen; Hans Henrik Gad; Rune Hartmann
Journal:  J Virol       Date:  2020-02-14       Impact factor: 5.103

Review 2.  Immune system control of hepatitis C virus infection.

Authors:  Johnasha D Stuart; Eduardo Salinas; Arash Grakoui
Journal:  Curr Opin Virol       Date:  2020-11-01       Impact factor: 7.090

3.  Interferon-free treatment for hepatitis C virus infection induces normalization of extrahepatic type I interferon signaling.

Authors:  Pil Soo Sung; Eun Byul Lee; Dong Jun Park; Angelo Lozada; Jeong Won Jang; Si Hyun Bae; Jong Young Choi; Seung Kew Yoon
Journal:  Clin Mol Hepatol       Date:  2018-03-12

Review 4.  Decoding type I and III interferon signalling during viral infection.

Authors:  Emily V Mesev; Robert A LeDesma; Alexander Ploss
Journal:  Nat Microbiol       Date:  2019-04-01       Impact factor: 17.745

Review 5.  Interferon Response in Hepatitis C Virus-Infected Hepatocytes: Issues to Consider in the Era of Direct-Acting Antivirals.

Authors:  Pil Soo Sung; Eui-Cheol Shin
Journal:  Int J Mol Sci       Date:  2020-04-08       Impact factor: 5.923

6.  Peripheral blood correlates of virologic relapse after Sofosbuvir and Ribavirin treatment of Genotype-1 HCV infection.

Authors:  Cody Orr; Wenjie Xu; Henry Masur; Shyam Kottilil; Eric G Meissner
Journal:  BMC Infect Dis       Date:  2020-12-04       Impact factor: 3.090

7.  Interferon Lambda 3/4 (IFNλ3/4) rs12979860 Polymorphisms Is Not Associated With Susceptibility to Systemic Lupus Erythematosus, Although It Regulates OASL Expression in Patients With SLE.

Authors:  Yaneli Juárez-Vicuña; Julia Pérez-Ramos; Laura Adalid-Peralta; Fausto Sánchez; Laura Aline Martínez-Martínez; María Del Carmen Ortiz-Segura; Edgar Pichardo-Ontiveros; Adrián Hernández-Díazcouder; Luis M Amezcua-Guerra; Julian Ramírez-Bello; Fausto Sánchez-Muñoz
Journal:  Front Genet       Date:  2021-06-02       Impact factor: 4.599

8.  Complex Autoinflammatory Syndrome Unveils Fundamental Principles of JAK1 Kinase Transcriptional and Biochemical Function.

Authors:  Conor N Gruber; Jorg J A Calis; Sofija Buta; Gilad Evrony; Jerome C Martin; Skyler A Uhl; Rachel Caron; Lauren Jarchin; David Dunkin; Robert Phelps; Bryn D Webb; Jeffrey M Saland; Miriam Merad; Jordan S Orange; Emily M Mace; Brad R Rosenberg; Bruce D Gelb; Dusan Bogunovic
Journal:  Immunity       Date:  2020-08-03       Impact factor: 31.745

9.  Longitudinal transcriptomic characterization of the immune response to acute hepatitis C virus infection in patients with spontaneous viral clearance.

Authors:  Brad R Rosenberg; Marion Depla; Catherine A Freije; Denis Gaucher; Sabrina Mazouz; Maude Boisvert; Nathalie Bédard; Julie Bruneau; Charles M Rice; Naglaa H Shoukry
Journal:  PLoS Pathog       Date:  2018-09-17       Impact factor: 6.823

10.  Expression of Interferons Lambda 3 and 4 Induces Identical Response in Human Liver Cell Lines Depending Exclusively on Canonical Signaling.

Authors:  Mariia Lunova; Jan Kubovciak; Barbora Smolková; Mariia Uzhytchak; Kyra Michalova; Alexandr Dejneka; Pavel Strnad; Oleg Lunov; Milan Jirsa
Journal:  Int J Mol Sci       Date:  2021-03-04       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.